The Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
The Rising Adoption of Cloud-Based Applications & Services Is Driving the Market
Artificial intelligence (AI) is defined as a machine that employs modern technology to do tasks that are similar to those performed by the human mind. The primary purpose of drug discovery research is to find medications that can aid in the prevention or treatment of specific diseases. The difficulties of reviewing, obtaining, and utilising data to solve difficult medical problems fueled demand for artificial intelligence (AI) in the drug discovery business. The market for artificial intelligence in drug development is divided into offering, technology, type, applications, and region. The growing number of cross-industry collaborations and partnerships, the increasing need to control drug discovery & development costs and reduce overall time taken in this process, the rising adoption of cloud-based applications & services, and the impending patent expiration of blockbuster drugs are all driving the artificial intelligence in drug discovery market. On the other side, the market’s expansion is being hampered by a paucity of data sets in the field of drug discovery and an insufficient supply of competent workers.
The Lack of Data Is a Recurring Problem Throughout All Industries Implementing AI
The shortage of data is a reoccurring issue in all industries that are deploying AI. A standard biological investigation requires a minimum of five samples to be legitimate. Meanwhile, in order to function well, most machine learning algorithms must be trained on hundreds of thousands of data points or samples. This is why obtaining high-quality healthcare data is critical something that has proven increasingly challenging over time. The challenge is due to the disorganised and fragmented health data scattered across many data platforms and organisations. Patients’ insurance and healthcare providers change too frequently, making data collection difficult.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the artificial intelligence (AI) in drug discovery market evolving?
• What is driving and restraining the artificial intelligence (AI) in drug discovery market?
• How will each artificial intelligence (AI) in drug discovery submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each artificial intelligence (AI) in drug discovery submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading artificial intelligence (AI) in drug discovery markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the artificial intelligence (AI) in drug discovery projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032?What are the implication of artificial intelligence (AI) in drug discovery projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the artificial intelligence (AI) in drug discovery market?
• Where is the artificial intelligence (AI) in drug discovery market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the artificial intelligence (AI) in drug discovery market today, and over the next 10 years:
• Our 461-page report provides 270 tables and 264 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the artificial intelligence (AI) in drug discovery market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Delivers exclusive COVID-19 variations economic data specific to your market.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising artificial intelligence (AI) in drug discovery prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Segments Covered in this report
Market Segment by Offering
• AI Software
• AI Services
Market Segment by Technology
• Deep Learning
• Supervised Learning
• Reinforcement Learning
• Unsupervised Learning
• Other Technology
Market Segment by Applications
• Oncology
• Infectious Diseases
• Neurological Disorders
• Metabolic Diseases
• Cardiovascular Diseases
• Other Applications
Market Segment by Type
• Target Identification
• Molecule Screening
• Drug Design and Drug Optimization
• Preclinical and Clinical Testing
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Rest of Latin America, Middle East and Africa
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Atomwise
• Benevolent AI
• Berg Health
• Bioage
• Biosymetrics
• Cloud Pharmaceuticals
• Cyclica
• Deep Genomics
• DeepMind
• Envisagenics
• Euretos
• Exscientia
• GNS Healthcare
• IBM Corporation
• Insilico Medicine
Overall world revenue for Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 in terms of value the market will surpass US$919 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market report helps you?
In summary, our 461-page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market, with forecasts for application, technology, type, offering, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 4 regional and 20 key national markets – See forecasts for the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032: Forecasts by Offering (AI Software, AI Services), by Technology (Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning, Other), by Applications (Oncology, Infectious Diseases, Neurological Disorders, Metabolic Diseases, Cardiovascular Diseases, Other), by Type (Target Identification, Molecule Screening, Drug Design and Drug Optimisation, Preclinical and Clinical Testing) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Introduction to Artificial Intelligence (AI) in Drug Discovery Market
1.2 Global Artificial Intelligence (AI) in Drug Discovery Market Overview
1.3 What Are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Artificial Intelligence (AI) in Drug Discovery Market Definition
1.6 Why You Should Read this Report
1.7 What this Report Delivers
1.8 Key Questions Answered by this Analytical Report Include:
1.9 Who is this Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Visiongain Reports
1.13 About Visiongain
2 Executive Summary
3 Artificial Intelligence (AI) in Drug Discovery Industry Structure
3.1 Overview
3.2 Industry Value Chain Analysis
3.3 Artificial Intelligence Is Changing Drug Discovery
3.4 Networks and Tools for AI
3.5 AI in the Pharmaceutical Product Lifecycle
3.6 AI in Drug Discovery
3.6.1 AI in Drug Design
3.6.2 AI in Polypharmocology
3.6.3 AI in Chemical Sythesis
3.6.4 AI in drug repurposing
3.6.5 AI in drug screening
3.7 AI in Drug Screening
3.8 AI in Designing Drug Molecules
3.9 AI in Advancing Pharmaceutical Product Development
3.10 AI in Pharmaceutical Manufacturing
4 Global Market Dynamics
4.1 Market Driving Factors
4.1.1 AI Utilizes the Latest Advances in Biology and Computing to Develop State-of-the-Art Algorithms for Drug Discovery
4.1.2 Thanks to AI, the Cost and Timelines of Developing a New Treatment Will Be Rewritten
4.1.3 Artificial Intelligence (AI) Has Been a Game-Changer for the Pharmaceutical Sector Throughout the Value Chain
4.2 Market Restraining Factors
4.2.1 AI Predictions Are as Good as the Algorithms Used to Investigate a Dataset
4.2.2 AI Can Suffer from Algorithm Bias
4.2.3 Setting Up AI-Based Machines, Computers Entails Huge Costs
4.3 Opportunities in the Global Market
4.3.1 A New Wave of Drug Discovery is Setting the Ideal for the World
4.3.2 AI Has Received a Lot of Attention in the Pharmaceutical Business for Medication Discovery and Development
4.3.3 Understanding the Molecular Causes of a Disease in a Precisely Stratified Patient Sample Is Critical for Drug Discovery Programmes to Hit the Mark and Prevent Late-Stage Effectiveness Failures
4.4 Challenges in the Global Market
4.4.1 The Lack of Data Is a Recurring Problem Throughout All Industries Implementing AI
4.4.2 AI Systems Are Prone to Errors, Which Eventually Leads to a Significant Problems
4.4.3 Another Hindrance in Using AI to Predict Drug Targets Remains to Translate Traditional Basic Research Conducted in Labs Worldwide into a Language That a Computer Can Understand
4.5 Swot Analysis for Global Market
4.5.1 Market Strengths
4.5.2 Market Weakness
4.5.3 Market Opportunites
4.5.4 Market Threats
4.6 PEST Analysis for Global Market
4.6.1 Political Factors
4.6.2 Economic Factors
4.6.3 Social Factors
4.6.4 Technology Factors
4.7 Porter’s Five Forces
4.7.1 Threats of New Entrants- High
4.7.2 Bargaining Power of Suppliers- High
4.7.3 Bargaining Power of Buyers- Low
4.7.4 Threats of Substitute - Low
4.7.5 Rivalry among the Existing Competitors - High
5 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis
5.1 Global Market Outlook
5.1.1 Global Artificial Intelligence (AI) in Drug Discovery Market is Expected to Grow at Rapid Pace Due to Huge Drugs Demand
5.1.2 The Adoption of AI Solutions in the Clinical Trial Process Eliminates Various Obstacles
6 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032
6.1 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Region
6.2 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
6.3 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
6.4 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
6.5 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type
7 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis
7.1 North America Market Outlook
7.1.1 North America Is the Largest Growing Regional Market for AI in Drug Discovery
7.1.2 Postera, a North American Biotechnology Company Specializing in Machine Learning for Preclinical Drug Discovery is Chosen for Further Innovation
7.2 US Artificial Intelligence in Drug Discovery Market Analysis
7.2.1 AI Spending and Funding in US is Getting the Light it Needs
7.2.2 The U.S. Has a Clear Advantage in the Race to Become an AI Superpower
7.3 Canada Artificial Intelligence in Drug Discovery Market Analysis
7.3.1 Canada Offers Resources to Local and Foreign AI-Focused Talent and Organizations
7.3.2 Companies Collaborations and Partnerships in Canada is Accelerating the Usecase of AI in Drug Development
7.4 Mexico Artificial Intelligence (AI) in Drug Discovery Market Analysis
7.4.1 Mexico is One of the First Ten Countries in the World to Adopt an Artificial Intelligence Policy, and it Leads Latin America
7.4.2 Role of Government in Helping to Shape the Development and Uses of AI in Mexico
7.5 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
7.6 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
7.7 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
7.8 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
8 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis
8.1 Europe Market Outlook
8.1.1 The EU’s Approach to Artificial Intelligence Centres on Excellence and Trust, Aiming to Boost Research and Industrial Capacity and Ensure Fundamental Rights
8.1.2 European Proposal for a Legal Framework on AI
8.2 Germany Artificial Intelligence (AI) in Drug Discovery Market Analysis
8.2.1 In Germany, an Algorithm Based on the Brain's Self-Organizing Capacity Has been Developed to Tackle Escalating Medication Development Costs
8.2.2 Germany is at the Forefront of Artificial Intelligence (AI) in Europe
8.3 UK Artificial Intelligence in Drug Discovery Market Analysis
8.3.1 There is Huge Increase in Demand for Ai Professionals in UK
8.3.2 AI could be a significant driver of productivity and GDP growth for the UK economy
8.4 France Artificial Intelligence in Drug Discovery Market Analysis
8.4.1 French Government Supports AI in Healthcare
8.4.2 French Companies Are Coming Together to Find Innovatiove Solutions for Drug Development
8.5 Italy Artificial Intelligence in Drug Discovery Market Analysis
8.5.1 Some Italian Companies Are Now Slowly Beginning to Pilot New Technologies Particularly in AI
8.5.2 Impact of AI on Italy’s Economy and Growth
8.6 Spain Artificial Intelligence in Drug Discovery Market Analysis
8.6.1 Impact of AI in Spain
8.6.2 IndesIA is a Spanish Association of Artificial Intelligence for Industry
8.7 Rest of Europe Artificial Intelligence in Drug Discovery Market Analysis
8.7.1 Ireland Has the Highest Share of Businesses Using AI Applications in Europe
8.7.2 European Commission Is Hoping to Set New Oversight Standards in a Bid to Create ‘Trustworthy AI’
8.8 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
8.9 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
8.10 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
8.11 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
8.12 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type
9 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis
9.1 Asia-Pacific Market Outlook
9.1.1 The Growing Startup Culture in Asian Countries Has Also Influenced the Growth of AI, Sspecially in Countries like China and India
9.1.2 Southeast Asia is Still in the Early Stages of AI Adoption
9.2 China Artificial Intelligence in Drug Discovery Market Analysis
9.2.1 Chinese Firms Are Relying on AI to Put More Drugs on the Market, and by Extrapolation Extend Better Services
9.2.2 Chinese Firm Marks the World’s First Phase-1 Clinical Trial of a Drug Developed with AI Technology from Scratch
9.3 India Artificial Intelligence in Drug Discovery Market Analysis
9.3.1 Intuition System, a Company from India is Heating up the Game in AI
9.3.2 Other Startups and Companies in India is on the Innovatiove Track Regarding AI in Drug Discovery
9.4 Japan Artificial Intelligence in Drug Discovery Market Analysis
9.4.1 A Powerful New Use for AI in Drug Discovery Has Been Discovered by a Japanese Company
9.4.2 The Pharmaceuticals and Medical Devices Agency (PDMA) Approved 123 New Drug Products in Japan
9.5 South Korea Artificial Intelligence in Drug Discovery Market Analysis
9.5.1 This South Korean Firm Is on the Cutting Edge of AI-Driven Drug Development
9.5.2 South Korea to Use AI in Drug Discovery as the Government Gives Approval
9.6 Australia Artificial Intelligence in Drug Discovery Market Analysis.
9.6.1 Experts from Two Australian University Groups Working on AI in Drug Development Are Supervising the Phd Research
9.6.2 Contribution of Australia in AI in Drug Discovery Research
9.7 Rest of Asia-Pacific Artificial Intelligence in Drug Discovery Market Analysis.
9.7.1 Southeast Asian Countries are also Committing to the Development and Research Involving AI
9.7.2 Singapore’s Leading Firm is Taking a Big Leap in AI
9.8 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
9.9 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
9.10 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
9.11 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
9.12 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type
10 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis
10.1 LAMEA Market Outlook
10.1.1 Latin America’s Growing Artificial Intelligence Wave Can Give Boost to the Low Productivity Countries
10.1.2 AI is Poised to Impact Africa in Several Ways in Drug Discovery
10.2 Brazil Artificial Intelligence in Drug Discovery Market Analysis.
10.2.1 The Brazilian House of Representatives Has Passed a Law that Establishes Legal Guidelines for Artificial Intelligence
10.2.2 Brazil Excels in the Use of Artificial Intelligence
10.3 Turkey Artificial Intelligence in Drug Discovery Market Analysis.
10.3.1 Turkey Plans to Become Among the Top 20 Countries in the International AI Indices
10.3.2 Artificial intelligence (AI) is the New “Oil” of the Near Future and can Provide Huge Opportunities for Turkey
10.4 Saudi Arabia Artificial Intelligence in Drug Discovery Market Analysis.
10.4.1 Saudi Arabia Uses AI in Drug Discovery
10.4.2 Saudi Arabia is Uniquely Placed to Drive Artificial Intelligence Innovation Post-Coronavirus Pandemic
10.5 South Africa Artificial Intelligence in Drug Discovery Market Analysis.
10.5.1 Innovations in South Africa in AI
10.5.2 South Africa to Participate in AI Driven Future in Health and Drug Development Sector
10.6 UAE Artificial Intelligence in Drug Discovery Market Analysis.
10.6.1 The UAE Government launched ‘UAE Strategy for Artificial Intelligence (AI)’
10.6.2 Drug Discovery from Artificial Intelligence Partnership Announced In UAE
10.7 Rest of LAMEA Artificial Intelligence in Drug Discovery Market Analysis.
10.7.1 AI’s applications in Latin America are already becoming reality in Drug Discovery
10.7.2 AI landscape in sub-Saharan Africa is Improving
10.8 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
10.9 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
10.10 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
10.11 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
10.12 LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis
11 Leading Company Analysis and Profile
11.1 Atomwise
11.1.1 Company Snapshot
11.1.2 Company Overview
11.1.3 Company Product Benchmarking
11.1.4 Company Recent Developments
11.2 Benevolent AI
11.2.1 Company Snapshot
11.2.2 Company Overview
11.2.3 Company Product Benchmarking
11.2.4 Company Recent Developments
11.3 Berg Health
11.3.1 Company Snapshot
11.3.2 Company Overview
11.3.3 Company Product Benchmarking
11.3.4 Company Recent Developments
11.4 Bioage
11.4.1 Company Snapshot
11.4.2 Company Overview
11.4.3 Company Product Benchmarking
11.4.4 Company Recent Developments
11.5 Biosymetrics
11.5.1 Company Snapshot
11.5.2 Company Overview
11.5.3 Company Product Benchmarking
11.5.4 Company Recent Developments
11.6 Cloud Pharmaceuticals
11.6.1 Company Snapshot
11.6.2 Company Overview
11.6.3 Company Product Benchmarking
11.7 Cyclica
11.7.1 Company Snapshot
11.7.2 Company Overview
11.7.3 Company Product Benchmarking
11.7.4 Company Recent Developments
11.8 Deep Genomics
11.8.1 Company Snapshot
11.8.2 Company Overview
11.8.3 Company Product Benchmarking
11.8.4 Company Recent Developments
11.9 DeepMind
11.9.1 Company Snapshot
11.9.2 Company Overview
11.9.3 Company Product Benchmarking
11.9.4 Company Recent Developments
11.10 Envisagenics
11.10.1 Company Snapshot
11.10.2 Company Overview
11.10.3 Company Product Benchmarking
11.10.4 Company Recent Developments
11.11 Euretos
11.11.1 Company Snapshot
11.11.2 Company Overview
11.11.3 Company Product Benchmarking
11.11.4 Company Recent Developments
11.12 Exscientia
11.12.1 Company Snapshot
11.12.2 Company Overview
11.12.3 Company Recent Developments
11.13 GNS Healthcare
11.13.1 Company Snapshot
11.13.2 Company Overview
11.13.3 Company Product Benchmarking
11.13.4 Company Recent Developments
11.14 IBM Corporation
11.14.1 Company Snapshot
11.14.2 Company Overview
11.14.3 Company Financial Profile
11.14.4 Company Product Benchmarking
11.14.5 Company Recent Developments
11.15 Insilico Medicine
11.15.1 Company Snapshot
11.15.2 Company Overview
11.15.3 Company Product Benchmarking
11.15.4 Company Recent Developments
12 Conclusion and Recommendations
12.1 Conclusion Summary
12.2 Recommendations
13 Glossary Terms
13.1 Associated Visiongain Reports
List of Tables
Table 1 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 2 Global Artificial Intelligence (AI) in Drug Discovery Market Snapshot, 2022 & 2032 (US$million, CAGR %)
Table 3 Artificial Intelligence (AI) in Drug Discovery Swot Analysis
Table 4 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 5 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 6 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 7 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 8 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 9 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 10 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 11 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 12 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 13 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 14 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 15 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 16 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 17 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 18 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 19 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 20 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 21 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 22 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 23 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 24 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 25 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 26 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 27 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 28 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 29 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 30 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 31 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 32 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 33 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 34 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 35 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 36 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 37 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 38 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 39 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 40 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 41 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 42 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 43 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 44 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 45 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 46 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 47 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 48 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 49 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 50 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 51 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 52 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 53 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 54 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 55 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 56 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 57 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 58 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 59 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 60 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 61 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 62 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 63 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 64 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 65 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 66 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 67 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 68 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 69 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 70 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 71 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 72 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 73 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 74 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 75 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 76 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 77 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 78 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 79 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 80 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 81 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 82 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 83 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 84 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 85 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 86 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 87 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 88 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 89 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 90 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 91 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 92 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 93 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 94 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 95 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 96 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 97 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 98 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 99 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 100 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 101 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 102 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 103 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 104 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 105 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 106 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 107 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 108 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 109 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 110 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 111 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 112 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 113 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 114 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 115 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 116 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 117 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 118 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 119 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 120 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 121 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 122 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 123 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 124 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 125 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 126 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 127 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 128 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 129 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 130 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 131 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 132 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 133 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 134 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 135 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 136 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 137 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 138 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 139 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 140 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 141 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 142 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 143 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 144 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 145 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 146 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 147 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 148 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 149 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 150 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 151 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 152 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 153 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 154 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 155 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 156 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 157 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 158 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 159 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 160 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 161 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 162 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 163 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 164 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 165 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 166 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 167 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 168 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 169 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 170 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 171 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 172 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 173 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 174 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 175 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 176 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 177 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 178 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 179 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 180 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 181 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 182 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 183 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 184 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 185 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 186 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 187 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 188 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 189 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 190 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 191 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 192 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 193 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 194 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 195 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 196 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 197 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 198 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 199 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 200 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 201 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 202 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 203 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 204 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 205 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 206 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 207 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 208 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 209 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 210 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 211 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 212 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 213 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 214 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 215 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 216 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 217 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 218 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 219 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 220 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 221 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 222 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 223 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 224 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 225 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 226 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 227 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 228 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 229 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 230 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 231 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 232 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 233 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 234 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 235 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 236 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 237 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 238 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 239 Atomwise: Company Information
Table 240 Atomwise: Company Product and Service Benchmarking
Table 241 Atomwise: Company Recent Developments
Table 242 Benevolent AI: Company Information
Table 243 Benevolent AI: Company Product and Service Benchmarking
Table 244 KKK: Company Recent Developments
Table 245 Berg Health: Company Information
Table 246 Berg Health: Company Product and Service Benchmarking
Table 247 Berg Health: Company Recent Developments
Table 248 Bioage: Company Information
Table 249 Bioage: Company Product and Service Benchmarking
Table 250 Bioage: Company Recent Developments
Table 251 Biosymetrics: Company Information
Table 252 Biosymetrics: Company Product and Service Benchmarking
Table 253 Cloud Pharmaceuticals: Company Information
Table 254 Cloud Pharmaceuticals:: Company Product and Service Benchmarking
Table 255 Cyclica: Company Information
Table 256 Cyclica: Company Product and Service Benchmarking
Table 257 Cyclica: Company Recent Developments
Table 258 Deep Genomics: Company Information
Table 259 Deep Genomics: Company Product and Service Benchmarking
Table 260 Deep Genomics: Company Recent Developments
Table 261 DeepMind: Company Information
Table 262 DeepMind: Company Product and Service Benchmarking
Table 263 Deepmind: Company Recent Developments
Table 264 Envisagenics: Company Information
Table 265 Envisagenics: Company Product and Service Benchmarking
Table 266 Envisagenics: Company Recent Developments
Table 267 Euretos: Company Information
Table 268 Euretos: Company Product and Service Benchmarking
Table 269 Euretos: Company Recent Developments
Table 270 Exscientia: Company Information
Table 271 Exscientia: Company Product and Service Benchmarking
Table 272 Exscientia: Company Recent Developments
Table 273 GNS Healthcare: Company Information
Table 274 GNS Healthcare: Company Product and Service Benchmarking
Table 275 GNS Healthcare: Company Recent Developments
Table 276 IBM Corporation: Company Information
Table 277 IBM Corporation: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 278 IBM Corporation: Company Product and Service Benchmarking
Table 279 IBM Corporation: Company Recent Developments
Table 280 Insilico Medicine: Company Information
Table 281 Insilico Medicine: Company Product and Service Benchmarking
Table 282 Insilico Medicine: Company Recent Developments
List of Figures
Figure 1 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 2 Global Artificial Intelligence (AI) in Drug Discovery Market Segmentation
Figure 3 Artificial Intelligence (AI) in Drug Discovery PEST Analysis
Figure 4 Artificial Intelligence (AI) in Drug Discovery Porter’s Five Forces.
Figure 5 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%))
Figure 6 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 7 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 8 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 9 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 10 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%))
Figure 11 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 12 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 13 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 14 Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 15 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
Figure 16 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 17 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 18 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 19 Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 20 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 21 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 22 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 23 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 24 Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 25 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
Figure 26 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 27 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 28 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 29 Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 30 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 31 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 32 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 33 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 34 Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 35 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 36 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 37 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 38 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 39 North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 40 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 41 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 42 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 43 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 44 US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 45 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 46 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 47 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 48 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 49 Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 50 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 51 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 52 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 53 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 54 Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 55 North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 56 North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 57 North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 58 North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 59 North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 60 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
Figure 61 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 62 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 63 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 64 North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 65 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 66 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 67 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 68 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 69 North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 70 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
Figure 71 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 72 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 73 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 74 North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 75 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 76 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 77 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 78 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 79 North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 80 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 81 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 82 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 83 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 84 Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 85 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 86 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 87 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 88 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 89 Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 90 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 91 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 92 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 93 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 94 UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 95 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 96 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 97 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 98 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 99 France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 100 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 101 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 102 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 103 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 104 Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 105 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 106 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 107 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 108 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 109 Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 110 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 111 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 112 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 113 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 114 Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 115 Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 116 Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 117 Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 118 Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 119 Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 120 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
Figure 121 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 122 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 123 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 124 Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 125 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 126 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 127 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 128 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 129 Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 130 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
Figure 131 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 132 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 133 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 134 Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 135 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 136 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 137 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 138 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 139 Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 140 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 141 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 142 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 143 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 144 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 145 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 146 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 147 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 148 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 149 China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 150 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 151 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 152 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 153 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 154 India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 155 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 156 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 157 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 158 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 159 Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 160 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 161 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 162 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 163 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 164 South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 165 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 166 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 167 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 168 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 169 Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 170 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 171 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 172 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 173 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 174 Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 175 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 176 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 177 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 178 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 179 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 180 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
Figure 181 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 182 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 183 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 184 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 185 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 186 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 187 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 188 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 189 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 190 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
Figure 191 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 192 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 193 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 194 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 195 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 196 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 197 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 198 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 199 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 200 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 201 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 202 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 203 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 204 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 205 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 206 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 207 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 208 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 209 Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 210 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 211 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 212 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 213 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 214 Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 215 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 216 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 217 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 218 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 219 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 220 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 221 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 222 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 223 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 224 South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 225 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 226 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 227 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 228 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 229 UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 230 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
Figure 231 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 232 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 233 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 234 Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 235 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%))
Figure 236 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 237 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 238 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 239 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 240 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
Figure 241 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 242 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 243 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 244 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 245 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
Figure 246 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 247 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 248 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 249 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 250 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
Figure 251 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 252 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 253 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 254 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 255 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
Figure 256 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 257 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 258 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 259 LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 260 IBM Corporation: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 261 AMCOR LTD: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 262 IBM Corporation: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 263 IBM Corporation: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 264 Global Artificial Intelligence (AI) in Drug Discovery Market Forecast by Artificial Intelligence (AI) in Drug Discovery 2022, 2027, 2032 (%)
List of Companies Profiled in the report
Atomwise
Benevolent AI
Berg Health
Bioage
Biosymetrics
Cloud Pharmaceuticals
Cyclica
Deep Genomics
DeepMind
Envisagenics
Euretos
Exscientia
GNS Healthcare
IBM Corporation
Insilico Medicine
List of Other Companies Mentioned in the report
Accenture
AdventHealth
AstraZeneca
ATAI Lifesciences AG
Bayer
BioMarin Pharmaceuticals, Inc.
BioMotiv
Blue Oak Pharmaceuticals
Boehringer Ingelheim
Bridge Biotherapeutics
Bristol Myers Squibb
Celgene
Cereval Therapeutics
Charles River Laboratories
Datavant
Deutsche Telekom
Diamond Light Source
DNDi
Eli Lilly and Company
Elsevier
Enamine, Ltd.
Eurofarma
Excelra
FMC Corporation
Gilead Sciences, Inc.
GitHub, Inc.
GlaxoSmithKline
Google, Inc.
GT Apeiron Therapeutics
Gustave Roussy
Hansoh Pharmaceutical Group Company Limited
Haystack Sciences
HollandBIO
Huadong Medicine
Instana
Janssen
Mannin Research
NeuroTheryX Canada, Ltd.
Novartis
Nuance Communications, Inc.
NYU Langone Health
Pfizer
Rallybio
Red Hat, Inc.
Roche
Sema4
ServiceNow
Sophia Genetics
SRI International
Sumitomo Dainippon Pharma
Temasek
UnitedHealth Group
Wave Life Sciences, Ltd.
WuXi AppTec
Zeiss Group
List of Associations Mentioned in the Report
Alliance for Clinical Trials in Oncology
Bill & Melinda Gates Foundation
Brigham and Women's Hospital
Cancer Research UK Imperial Centre
CINECA
Duke University
FedDev Ontario
Genome Institute
Harvard Medical School
Institut Carnot CALYM
Merck Global Health Innovation Fund
Multiple Myeloma Research Foundation
U-M Life Sciences Institute
University of California
University of Michigan College of Pharmacy
University of Pittsburgh
Vanderbilt University Medical Center
World Health Organization
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
